JP5451641B2 - モード規定要素を備えた注射装置 - Google Patents
モード規定要素を備えた注射装置 Download PDFInfo
- Publication number
- JP5451641B2 JP5451641B2 JP2010545485A JP2010545485A JP5451641B2 JP 5451641 B2 JP5451641 B2 JP 5451641B2 JP 2010545485 A JP2010545485 A JP 2010545485A JP 2010545485 A JP2010545485 A JP 2010545485A JP 5451641 B2 JP5451641 B2 JP 5451641B2
- Authority
- JP
- Japan
- Prior art keywords
- mode defining
- dose
- defining element
- injection
- injection device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002347 injection Methods 0.000 title claims abstract description 169
- 239000007924 injection Substances 0.000 title claims abstract description 169
- 230000007246 mechanism Effects 0.000 claims abstract description 61
- 230000033001 locomotion Effects 0.000 claims abstract description 50
- 239000003814 drug Substances 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 230000004044 response Effects 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 abstract description 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 4
- DDYAPMZTJAYBOF-ZMYDTDHYSA-N (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S,3S)-1-[[(1S)-1-carboxyethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid Chemical class [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DDYAPMZTJAYBOF-ZMYDTDHYSA-N 0.000 description 3
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- -1 GLP-1 compound Chemical class 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 1
- 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 1
- 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3156—Mechanically operated dose setting member using volume steps only adjustable in discrete intervals, i.e. individually distinct intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2006—Having specific accessories
- A61M2005/202—Having specific accessories cocking means, e.g. to bias the main drive spring of an injector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/3159—Dose expelling manners
- A61M5/31591—Single dose, i.e. individually set dose administered only once from the same medicament reservoir, e.g. including single stroke limiting means
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
−所定の用量を設定するために操作可能な用量設定機構と、
−設定された用量を注射装置によって注射するために操作可能な注射機構と、
−ねじりばねであって、用量設定機構の操作によってねじりばねにエネルギーが蓄えられるように用量設定機構に連結されており、且つ注射機構の操作によって予めねじりばねに蓄えられたエネルギーを放出して、放出されたエネルギーが設定された用量の注射に使用されるように注射機構に連結されたねじりばねと
−用量設定機構の操作に応じて互いに対して角運動可能な第1モード規定要素と第2モード規定要素であって、用量を設定するために用量設定機構を操作することができる第1位置と、設定された用量を注射するために注射機構を操作することができる第2位置との間で互いに対して軸方向運動可能である第1モード規定要素と第2モード規定要素と
を具備しており、モード規定要素が、第1位置と第2位置との間における相対的軸方向運動が限定された数の相対的角度位置でのみ可能であるように形成されており、前記角度位置の各々が薬液の所定の用量の設定に対応している。
Claims (13)
- 所定の用量の薬液を注射するための注射装置であって、
−所定の用量を設定するために操作可能な用量設定機構と、
−設定された用量を注射装置によって注射するために操作可能な注射機構と、
−ねじりばねであって、前記用量設定機構の操作によって前記ねじりばねにエネルギーが蓄えられるように前記用量設定機構に連結されており、且つ前記注射機構の操作によって予め前記ねじりばねに蓄えられたエネルギーを放出して、放出されたエネルギーが設定された用量の注射に使用されるように前記注射機構に連結されたねじりばねと、
−前記用量設定機構の操作に応じて互いに対して角運動可能な第1モード規定要素及び第2モード規定要素であって、用量を設定するために前記用量設定機構を操作することができる第1位置と、設定された用量を注射するために前記注射機構を操作することができる第2位置との間で互いに対して軸方向運動可能である第1及び第2モード規定要素と
を具備しており、前記モード規定要素が、前記第1位置と前記第2位置との間における相対的軸方向運動が限定された数の相対的角度位置でのみ可能であるように形成されており、前記角度位置の各々が薬液の所定の用量の設定に対応している、注射装置。 - 前記モード規定要素が、前記第1位置と前記第2位置との間における前記相対的軸方向運動が2つの相対的角度位置でのみ可能であるように形成されており、前記角度位置の一方が薬液のゼロではない所定の用量の設定に対応しており、前記角度位置の他方がゼロの用量に対応している、請求項1記載の注射装置。
- 前記第1モード規定要素が突出部分を備え、前記第2モード規定要素が角度的間隔をおいて分配された限定された数の切欠きを有し、各切欠きの形状と大きさとが、前記第1モード規定要素の前記突出部分を通過させることができるように決定されており、それによって前記突出部分の角度位置が前記切欠きの一つの角度位置に対応しているときにのみ、前記第1モード規定要素と前記第2モード規定要素とが互いに対して軸方向運動可能である、請求項1又は2に記載の注射装置。
- 前記モード規定要素が更に、互いの第3軸方向位置に移動可能であり、前記モード規定要素が前記第3軸方向位置に位置しているとき、前記モード規定要素間の相対的角運動が阻止される、請求項1〜3のいずれか一つに記載の注射装置。
- かみ合う歯の組が前記第1モード規定要素と前記第2モード規定要素とに形成されており、前記モード規定要素が前記第3軸方向位置にあるとき、前記かみ合う歯の組がかみ合う、請求項4記載の注射装置。
- 前記第3軸方向位置が前記第1軸方向位置と前記第2軸方向位置との間に配置されている、請求項4又は5記載の注射装置。
- 前記モード規定要素が前記第3軸方向位置にあるとき、前記用量設定機構が用量設定の操作不可能である、請求項4〜6のいずれか一つに記載の注射装置。
- 予め設定された用量が完全に注射されたときにのみ、前記第3軸方向位置から前記第1軸方向位置への前記モード規定要素の運動が可能である、請求項4〜7のいずれか一つに記載の注射装置。
- 前記モード規定要素が、注射の終了時に前記第1位置に自動的に戻るように構成されている、請求項1〜8のいずれか一つに記載の注射装置。
- 前記第1位置への自動的な戻りが、機械的な付勢手段によって行われる、請求項9記載の注射装置。
- 更に、所定の用量の大きさを予備調節するための調節手段を具備している、請求項1〜10のいずれか一つに記載の注射装置。
- 前記調節手段が、用量設定中に前記第1モード規定要素と前記第2モード規定要素との間の相対的な角運動を制限する調節可能位置規定形状を有する、請求項11記載の注射装置。
- 前記調節手段が、前記第2モード規定要素の少なくとも一部を構成する、請求項12記載の注射装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08151180 | 2008-02-07 | ||
EP08151180.0 | 2008-02-07 | ||
PCT/EP2009/051389 WO2009098299A1 (en) | 2008-02-07 | 2009-02-06 | Injection device having mode defining elements |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011510775A JP2011510775A (ja) | 2011-04-07 |
JP5451641B2 true JP5451641B2 (ja) | 2014-03-26 |
Family
ID=39563876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010545485A Active JP5451641B2 (ja) | 2008-02-07 | 2009-02-06 | モード規定要素を備えた注射装置 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110098658A1 (ja) |
EP (1) | EP2249905B1 (ja) |
JP (1) | JP5451641B2 (ja) |
CN (1) | CN101939035B (ja) |
AT (1) | ATE529148T1 (ja) |
WO (1) | WO2009098299A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0918145D0 (en) | 2009-10-16 | 2009-12-02 | Owen Mumford Ltd | Injector apparatus |
EP2624882B1 (en) | 2010-10-06 | 2021-04-28 | Ypsomed AG | Locking and retaining mechanism for the needle guard sleeve of an injection device |
TWI464003B (zh) * | 2010-11-18 | 2014-12-11 | Shl Group Ab | 藥物輸送裝置 |
US20140312074A1 (en) * | 2011-12-06 | 2014-10-23 | Novo Nordisk A/S | Drive Mechanism for an Injection Device and a Method of Assembling an Injection Device Incorporating Such Drive Mechanism |
US9901685B2 (en) | 2012-01-27 | 2018-02-27 | Novo Nordisk A/S | Injection device with a sliding scale |
WO2015007807A1 (en) * | 2013-07-17 | 2015-01-22 | Sanofi | Counting mechanism for a drug delivery device |
EP3046606A1 (en) * | 2013-09-16 | 2016-07-27 | Novo Nordisk A/S | Injection device for selective fixed or variable dosing |
AR098642A1 (es) * | 2013-12-09 | 2016-06-01 | Sanofi Aventis Deutschland | Elemento accionador y mecanismo para un dispositivo de suministro de fármaco y dispositivo de suministro de fármaco |
US10688247B2 (en) * | 2017-07-13 | 2020-06-23 | Haselmeier Ag | Injection device with flexible dose selection |
US11969583B2 (en) * | 2018-07-17 | 2024-04-30 | Medmix Switzerland Ag | Injection device with dose interruption fail safe |
WO2020069528A1 (en) * | 2018-09-28 | 2020-04-02 | Achilleus LLC | Secure device for delivering medications |
CN113613694B (zh) * | 2019-02-19 | 2024-04-30 | 迈德米斯瑞士股份公司 | 具有用户友好的剂量选择器的注射装置 |
USD988507S1 (en) * | 2019-12-23 | 2023-06-06 | Sanofi | Medical injection device |
USD989279S1 (en) * | 2020-11-24 | 2023-06-13 | Takeda Pharmaceutical Company Limited | Fluid delivery device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ539404A (en) * | 2000-10-09 | 2007-05-31 | Lilly Co Eli | Pen device for administration of parathyroid hormone |
DE102004045326A1 (de) * | 2004-04-23 | 2005-11-17 | Tecpharma Licensing Ag | Injektionsgerät mit mehrfach verdrehsicherbarer Dosiereinrichtung |
NZ554384A (en) * | 2004-10-04 | 2010-04-30 | Sanofi Aventis Deutschland | Drive mechanism for drug delivery device |
US7686786B2 (en) * | 2004-10-21 | 2010-03-30 | Novo Nordiks A/S | Dial-down mechanism for wind-up pen |
GB0524604D0 (en) * | 2005-12-02 | 2006-01-11 | Owen Mumford Ltd | Injection method and apparatus |
RU2433840C2 (ru) * | 2006-05-18 | 2011-11-20 | Ново Нордиск А/С | Инъецирующее устройство со средством блокирования функции |
-
2009
- 2009-02-06 JP JP2010545485A patent/JP5451641B2/ja active Active
- 2009-02-06 US US12/866,335 patent/US20110098658A1/en not_active Abandoned
- 2009-02-06 AT AT09707601T patent/ATE529148T1/de not_active IP Right Cessation
- 2009-02-06 CN CN200980104469.7A patent/CN101939035B/zh active Active
- 2009-02-06 EP EP09707601A patent/EP2249905B1/en active Active
- 2009-02-06 WO PCT/EP2009/051389 patent/WO2009098299A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ATE529148T1 (de) | 2011-11-15 |
WO2009098299A1 (en) | 2009-08-13 |
EP2249905B1 (en) | 2011-10-19 |
EP2249905A1 (en) | 2010-11-17 |
US20110098658A1 (en) | 2011-04-28 |
CN101939035A (zh) | 2011-01-05 |
JP2011510775A (ja) | 2011-04-07 |
CN101939035B (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5451641B2 (ja) | モード規定要素を備えた注射装置 | |
JP5479362B2 (ja) | 固定用量の液体薬剤を送達するための注射装置 | |
RU2401134C2 (ru) | Инъекционное устройство с механизмом обратной связи для сообщения о завершении введения дозы препарата | |
AU2007253481B2 (en) | An injection device with mode locking means | |
US9463283B2 (en) | Dosing mechanism for a drug deliver device | |
TWI569840B (zh) | 藥物輸送裝置 | |
JP4897920B2 (ja) | 注射装置のための反対回転可能な投与量設定機構 | |
JP6002130B2 (ja) | 薬物送達デバイス用のアセンブリ、ピストンロッド及び薬物送達デバイス | |
JP2018011970A (ja) | 調整可能な投与量の液剤を注射する装置 | |
US20230277776A1 (en) | Drive mechanism for an injection device | |
US9604007B2 (en) | Medical injection system comprising a medical injection device and a dose limiter module | |
US20210187201A1 (en) | Injection device with a preselector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120124 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130328 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130409 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130527 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131203 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5451641 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |